CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on identifying selective modulators of microRNAs, which are small RNA molecules that regulate gene expression. By using fragment-based drug discovery methods, the project aims to develop new therapeutic strategies targeting microRNAs associated with diseases like cancer and viral infections.
MicroRNAs have been identified as important endogenous regulators of gene function.
Aberrant regulation of them has been linked to various human diseases.
Small molecule intervention has the potential to provide a new therapeutic strategy.
The aim of the project is the identification of selective microRNA modulators by fragment-based drug discovery (FBDD) approaches.MicroRNAs are short ribonucleic acid (RNA) molecules, on average only 22 nucleotides long that act as post-transcriptional regulato…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
